Recombinant Human MX1 protein (His tag N-Terminus)
Recombinant Human MX1 protein (His tag N-Terminus)
Be the first to review this product! Submit a review
|
(0 Publication)
Recombinant Human MX1 protein is a Human Full Length protein in the 1 to 662 aa range with >90% purity and suitable for SDS-PAGE. The predicted molecular weight of ab187486 protein is 77.9 kDa.
- Save time and ensure accurate results - use our recombinant human MX1/MXA protein as a control
別名を表示する
Interferon-induced GTP-binding protein Mx1, Interferon-induced protein p78, Interferon-regulated resistance GTP-binding protein MxA, Myxoma resistance protein 1, Myxovirus resistance protein 1, IFI-78K, MX1
- SDS-PAGE
Supplier Data
SDS-PAGE - Recombinant Human MX1 protein (His tag N-Terminus) (AB187486)
15% SDS-PAGE analysis of ab187486 (3 μg).
Reactivity data
製品の詳細
Check out our protein gel staining guide for SDS-PAGE here
配列情報
出荷温度及び保存条件
製品の状態
出荷温度
短期保存期間
短期保存温度
長期保存温度
分注に関する情報
保管に関する情報
一般的な情報
機能
Interferon-induced dynamin-like GTPase with antiviral activity against a wide range of RNA viruses and some DNA viruses. Its target viruses include negative-stranded RNA viruses and HBV through binding and inactivation of their ribonucleocapsid. May also antagonize reoviridae and asfarviridae replication. Inhibits thogoto virus (THOV) replication by preventing the nuclear import of viral nucleocapsids. Inhibits La Crosse virus (LACV) replication by sequestering viral nucleoprotein in perinuclear complexes, preventing genome amplification, budding, and egress. Inhibits influenza A virus (IAV) replication by decreasing or delaying NP synthesis and by blocking endocytic traffic of incoming virus particles. Enhances ER stress-mediated cell death after influenza virus infection. May regulate the calcium channel activity of TRPCs.
配列の類似性
Belongs to the TRAFAC class dynamin-like GTPase superfamily. Dynamin/Fzo/YdjA family.
翻訳後修飾
ISGylated.
細胞内局在性
Nucleus
ターゲットの情報
Abcam product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com